These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8440573)

  • 41. [Hepatic encephalopathy--therapy].
    Wettstein M; Häussinger D
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2658-60. PubMed ID: 14673743
    [No Abstract]   [Full Text] [Related]  

  • 42. [2 cases of metabolic acidosis during therapy of portosystemic encephalopathy with branched-chain amino acids].
    Gambelli F; Antoniazzi V; Meregalli M; Torchio G
    Minerva Med; 1986 Mar; 77(9-10):321-2. PubMed ID: 3951734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
    Ferenci P; Grimm G; Meryn S; Gangl A
    Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?
    Vergara M; Castro-Gutiérrez V; Rada G
    Medwave; 2016 Dec; 16(Suppl5):e6795. PubMed ID: 28024140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of branched chain amino acid-enriched amino acid solution on normalization of plasma amino acids in hepatic encephalopathy.
    Liaw KY; Chang CN; Wei TC; Lin JK
    Taiwan Yi Xue Hui Za Zhi; 1985 Mar; 84(3):331-8. PubMed ID: 3860605
    [No Abstract]   [Full Text] [Related]  

  • 46. Sulfur-containing amino acids in experimental hepatic coma in the dog and the monkey.
    Smith AR; Rossi-Fanelli F; Freund H; Fischer JE
    Surgery; 1979 Jun; 85(6):677-83. PubMed ID: 109939
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
    Rossi Fanelli F; Cangiano C; Capocaccia L; Cascino A; Ceci F; Muscaritoli M; Giunchi G
    Gut; 1986 Nov; 27 Suppl 1(Suppl 1):111-5. PubMed ID: 3539709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of prostaglandins, branched-chain amino acids and other drugs on the outcome of experimental acute porcine hepatic failure.
    Alp MH; Hickman R
    J Hepatol; 1987 Feb; 4(1):99-107. PubMed ID: 3571937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure.
    Kitzberger R; Funk GC; Holzinger U; Miehsler W; Kramer L; Kaider A; Ferenci P; Madl C
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):1000-6. PubMed ID: 19465152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Flumazenil in the treatment of hepatic encephalopathy].
    Pintanel T; Font MM; García-Guasch R
    Med Clin (Barc); 1990 Jun; 95(4):157. PubMed ID: 2250539
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatic encephalopathy: a clinical analysis of 107 cases].
    Wang XG
    Zhonghua Wai Ke Za Zhi; 1988 Jul; 26(7):396-9, 444-5. PubMed ID: 3229250
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Awakening effects of branched-chain amino acid infusion in hepatic coma].
    Kaito I; Suzuki K; Kato A; Sato S
    Nihon Rinsho; 1982; 40(4):811-6. PubMed ID: 7098051
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnosis and treatment of chronic hepatic encephalopathy.
    Seery JP; Aspinall RJ; Taylor-Robinson SD
    Hosp Med; 1998 Mar; 59(3):200-4. PubMed ID: 9722346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic Management of Hepatic Encephalopathy.
    Mahpour NY; Pioppo-Phelan L; Reja M; Tawadros A; Rustgi VK
    Clin Liver Dis; 2020 May; 24(2):231-242. PubMed ID: 32245530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Acute effect of flumazenil in refractory hepatic encephalopathy].
    Chesta J; Brahm J; Poniachik J
    Rev Med Chil; 1989 Sep; 117(9):1049-50. PubMed ID: 2519472
    [No Abstract]   [Full Text] [Related]  

  • 59. Flumazenil in the treatment of hepatic encephalopathy.
    Howard CD; Seifert CF
    Ann Pharmacother; 1993 Jan; 27(1):46-8. PubMed ID: 8431621
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatic encephalopathy: new light on an old problem.
    Jones EA; Gammal SH; Martin P
    Q J Med; 1988 Nov; 69(259):851-67. PubMed ID: 3152130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.